Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.

Statins are widely used hypocholesterolemic drugs that block the mevalonate pathway, responsible for the biosysnthesis of cholesterol. However, statins also have pleiotropic effects that interfere with several signaling pathways. Mesenchymal stromal cells (MSC) are a heterogeneous mixture of cells t...

Full description

Bibliographic Details
Main Authors: Dalila Lucíola Zanette, Julio Cesar Cetrulo Lorenzi, Rodrigo Alexandre Panepucci, Patricia Vianna Bonini Palma, Daiane Fernanda Dos Santos, Karen Lima Prata, Wilson Araújo Silva
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395223?pdf=render
id doaj-4ffb19ac808d4ee5b62f7c14552b4f43
record_format Article
spelling doaj-4ffb19ac808d4ee5b62f7c14552b4f432020-11-25T01:26:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012013710.1371/journal.pone.0120137Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.Dalila Lucíola ZanetteJulio Cesar Cetrulo LorenziRodrigo Alexandre PanepucciPatricia Vianna Bonini PalmaDaiane Fernanda Dos SantosKaren Lima PrataWilson Araújo SilvaStatins are widely used hypocholesterolemic drugs that block the mevalonate pathway, responsible for the biosysnthesis of cholesterol. However, statins also have pleiotropic effects that interfere with several signaling pathways. Mesenchymal stromal cells (MSC) are a heterogeneous mixture of cells that can be isolated from a variety of tissues and are identified by the expression of a panel of surface markers and by their ability to differentiate in vitro into osteocytes, adipocytes and chondrocytes. MSC were isolated from amniotic membranes and bone marrows and characterized based on ISCT (International Society for Cell Therapy) minimal criteria. Simvastatin-treated cells and controls were directly assayed by CFSE (Carboxyfluorescein diacetate succinimidyl ester) staining to assess their cell proliferation and their RNA was used for microarray analyses and quantitative PCR (qPCR). These MSC were also evaluated for their ability to inhibit PBMC (peripheral blood mononuclear cells) proliferation. We show here that simvastatin negatively modulates MSC proliferation in a dose-dependent way and regulates the expression of proliferation-related genes. Importantly, we observed that simvastatin increased the percentage of a subset of smaller MSC, which also were actively proliferating. The association of MSC decreased size with increased pluripotency and the accumulating evidence that statins may prevent cellular senescence led us to hypothesize that simvastatin induces a smaller subpopulation that may have increased ability to maintain the entire pool of MSC and also to protect them from cellular senescence induced by long-term cultures/passages in vitro. These results may be important to better understand the pleiotropic effects of statins and its effects on the biology of cells with regenerative potential.http://europepmc.org/articles/PMC4395223?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Dalila Lucíola Zanette
Julio Cesar Cetrulo Lorenzi
Rodrigo Alexandre Panepucci
Patricia Vianna Bonini Palma
Daiane Fernanda Dos Santos
Karen Lima Prata
Wilson Araújo Silva
spellingShingle Dalila Lucíola Zanette
Julio Cesar Cetrulo Lorenzi
Rodrigo Alexandre Panepucci
Patricia Vianna Bonini Palma
Daiane Fernanda Dos Santos
Karen Lima Prata
Wilson Araújo Silva
Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
PLoS ONE
author_facet Dalila Lucíola Zanette
Julio Cesar Cetrulo Lorenzi
Rodrigo Alexandre Panepucci
Patricia Vianna Bonini Palma
Daiane Fernanda Dos Santos
Karen Lima Prata
Wilson Araújo Silva
author_sort Dalila Lucíola Zanette
title Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
title_short Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
title_full Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
title_fullStr Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
title_full_unstemmed Simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
title_sort simvastatin modulates mesenchymal stromal cell proliferation and gene expression.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Statins are widely used hypocholesterolemic drugs that block the mevalonate pathway, responsible for the biosysnthesis of cholesterol. However, statins also have pleiotropic effects that interfere with several signaling pathways. Mesenchymal stromal cells (MSC) are a heterogeneous mixture of cells that can be isolated from a variety of tissues and are identified by the expression of a panel of surface markers and by their ability to differentiate in vitro into osteocytes, adipocytes and chondrocytes. MSC were isolated from amniotic membranes and bone marrows and characterized based on ISCT (International Society for Cell Therapy) minimal criteria. Simvastatin-treated cells and controls were directly assayed by CFSE (Carboxyfluorescein diacetate succinimidyl ester) staining to assess their cell proliferation and their RNA was used for microarray analyses and quantitative PCR (qPCR). These MSC were also evaluated for their ability to inhibit PBMC (peripheral blood mononuclear cells) proliferation. We show here that simvastatin negatively modulates MSC proliferation in a dose-dependent way and regulates the expression of proliferation-related genes. Importantly, we observed that simvastatin increased the percentage of a subset of smaller MSC, which also were actively proliferating. The association of MSC decreased size with increased pluripotency and the accumulating evidence that statins may prevent cellular senescence led us to hypothesize that simvastatin induces a smaller subpopulation that may have increased ability to maintain the entire pool of MSC and also to protect them from cellular senescence induced by long-term cultures/passages in vitro. These results may be important to better understand the pleiotropic effects of statins and its effects on the biology of cells with regenerative potential.
url http://europepmc.org/articles/PMC4395223?pdf=render
work_keys_str_mv AT dalilaluciolazanette simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
AT juliocesarcetrulolorenzi simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
AT rodrigoalexandrepanepucci simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
AT patriciaviannaboninipalma simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
AT daianefernandadossantos simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
AT karenlimaprata simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
AT wilsonaraujosilva simvastatinmodulatesmesenchymalstromalcellproliferationandgeneexpression
_version_ 1725107649094090752